Claret Asset Management’s Boston Scientific BSX Stock Holding History

Claret Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Buy	+5,302	New	+$288K	0.02%	357
2026 Q1	–	Sell	-2,395	Closed	-$228K	–	362
2025 Q4	$228K	Sell	2,395 -5	-0.2%	-$490	0.03%	311
2025 Q3	$234K	Buy	2,400 +102	+4%	+$10.6K	0.03%	308
2025 Q2	$247K	Sell	2,298 -389	-14%	-$39.4K	0.03%	170
2025 Q1	$271K	Buy	2,687 +2	+0.1%	+$201	0.04%	160
2024 Q4	$240K	Buy	2,685 +17	+0.6%	+$1.5K	0.04%	196
2024 Q3	$224K	Buy	2,668 +13	+0.5%	+$1.02K	0.04%	239
2024 Q2	$204K	Buy	+2,655	New	+$194K	0.04%	194

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Claret Asset Management's BSX Position: Q2 2026 in Review

Claret Asset Management opened a new position in Boston Scientific (BSX) in Q2 2026: 5,302 shares worth $226K. The stake represents 0.02% of the portfolio and ranks #357 among its holdings. This is a return to the name: Claret Asset Management previously reported a position in BSX as recently as Q4 2025.

Claret Asset Management first reported a position in BSX in Q2 2024 and has held it in 8 quarters since. The position peaked at $271K in Q1 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Claret Asset Management held 5,302 shares of Boston Scientific worth $226K as of Q2 2026.
Boston Scientific was a new Claret Asset Management position in Q2 2026.
Boston Scientific made up 0.02% of Claret Asset Management's portfolio in Q2 2026, its #357 holding.
Claret Asset Management first reported a position in Boston Scientific in Q2 2024 and has held it in 8 quarters since.
Claret Asset Management's Boston Scientific position peaked at $271K in Q1 2025.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.